U.S. High Growth Potential Companies

Core Scientific

Market Cap: US$2.1b

Provides digital asset mining services in the United States.

Bitdeer Technologies Group

Market Cap: US$1.9b

Operates as a technology company for blockchain and computing.

Red Cat Holdings

Market Cap: US$452.5m

Provides various products, services, and solutions to the drone industry in the United States.

Palantir Technologies

Market Cap: US$236.5b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

AST SpaceMobile

Market Cap: US$7.3b

Designs and develops the constellation of BlueBird satellites in the United States.

DLocal

Market Cap: US$2.5b

Operates a payment processing platform worldwide.

ArcLight Clean Transition II

Market Cap: US$303.0m

As of July 21, 2022, ArcLight Clean Transition Corp.

A2Z Cust2Mate Solutions

Market Cap: US$276.1m

A technology company, focuses on the development and commercialization of retail smart cart solutions for grocery stores and supermarkets in Israel and internationally.

Myomo

Market Cap: US$154.4m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Apollo Commercial Real Estate Finance

Market Cap: US$1.2b

Apollo Commercial Real Estate Finance, Inc.

Loop Industries

Market Cap: US$52.4m

A technology company, focuses on depolymerizing waste polyethylene terephthalate PET plastics and polyester fibers, including plastic bottles, packaging, carpets and textiles of any color, transparency and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

Roadzen

Market Cap: US$63.4m

Operates as an insurance technology company.

OS Therapies

Market Cap: US$32.9m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Checkpoint Therapeutics

Market Cap: US$338.4m

A clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Ryan Specialty Holdings

Market Cap: US$18.4b

Operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore.

ADS-TEC Energy

Market Cap: US$688.9m

Engages in the provision of intelligent and decentralized energy storage systems in Europe and North America.

Establishment Labs Holdings

Market Cap: US$830.2m

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Luckin Coffee

Market Cap: US$10.3b

Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.

Delcath Systems

Market Cap: US$396.5m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Financial Institutions

Market Cap: US$467.6m

Through its subsidiaries, provides banking and financial services to consumer, commercial, and municipal customers in New York.

Evoke Pharma

Market Cap: US$5.2m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

SideChannel

Market Cap: US$9.3m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

Hess Midstream

Market Cap: US$8.6b

Owns, operates, develops, and acquires midstream assets and provide fee-based services to Hess and third-party customers in the United States.

Predictive Oncology

Market Cap: US$8.0m

A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies.

TruGolf Holdings

Market Cap: US$10.9m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.

Zapp Electric Vehicles Group

Market Cap: US$2.6m

Designs, manufactures, and sells electric vehicles under the Zapp brand.

Silence Therapeutics

Market Cap: US$144.0m

A biotechnology company, engages in the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Aldeyra Therapeutics

Market Cap: US$138.5m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Madrigal Pharmaceuticals

Market Cap: US$6.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

RenovoRx

Market Cap: US$34.7m

A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Abeona Therapeutics

Market Cap: US$256.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Remitly Global

Market Cap: US$3.9b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

Tenaya Therapeutics

Market Cap: US$73.5m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

loanDepot

Market Cap: US$361.8m

Engages in originating, financing, selling, and servicing residential mortgage loans in the United States.

Intchains Group

Market Cap: US$88.1m

Designs and sells application-specific integrated circuit chips for blockchain applications in the People’s Republic of China.

UroGen Pharma

Market Cap: US$463.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.